Dementia in the elderly: An overview

Generations

Volumn 23, Issue 3, 1999, Pages 9-16

  Epstein, David K ^a   Connor, James R ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0039029201     PISSN: 07387806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Breitner, J. C. 1996. "The Role of Anti-Inflammatory Drugs in the Prevention and Treatment of Alzheimer's Disease." Annual Review of Medicine 47: 401-11.
2. Brown, P. 1980. "An Epidemiologic Critique of Creutzfeldt-Jakob Disease." Epidemiology Renew 2:113-35.
3. Butler, R. N. 1993. "Vascular Dementia: How to Make the Diagnosis in Office Practice." Geriatrics 48: 39-42.
4. Casini, P. M., et al. 1996. "Prevalence of Dementia in an Elderly Rural Population: Effects of Age, Sex, And Education." Journal of Neurology, Neurosurgery, and Psychiatry 60 (6): 628-33.
5. Connor, J.R. 1997. Metals and Oxidative Damage in Neurological Disorders. New York: Plenum Press.
6. Corder, E. H., et al. 1993. "Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease." Science 261:921.
7. Crapper, D. R., Krishnan, S. S., and Dalton, A. J. 1973. "Brain Aluminum Distribution in Alzheimer's Disease and Experimental Neurofibrillary Degeneration." Science 180:511-13.
8. Hsiao, K., et al. 1996. "Correlative Memory Deficits, Aβ Elevation and Amyloid Plaques in Transgenic Mice" Science 274: 99-102.
9. Jellinger, K. 1990. "Clinico-Pathological Analysis of Dementia Disorders in the Elderly." Journal of Neurological Science 95:239-58.
10. Karzman, R. 1976. "The Prevalence and Malignancy of Alzheimer's Disease." Archives of Neurology 33: 217.
11. Mattson, M., et al. 1993. "Evidence for Excitoprotective and Intraneuronal Calcium-Regulating Roles for Secreted Forms of the Beta-Amyloid Precursor Protein." Neuron 10:243-54.
12. Mayeux, R., et al. 1993. "Genetic Susceptibility and Head Injury as Risk Factors for Alzheimer's Disease Among Community-Dwelling Elderly Persons and Their First-Degree Relatives? Annals of Neurology 33:494-501.
13. Mielke, R., and Heiss, W. D. 1998. "Positron Emission Tomography for Diagnosis of Alzheimer's Disease and Vascular Dementia." In K. Jellinger, F. Fazekas, and M. Windisch, eds., Ageing and Dementia. New York: Springer Wein.
14. Mucke, L., et al. 1994. "Synaptotrophic Effects of Human Amyloid Beta Protein Precursors in the Cortex of Transgenic Mice." Brain Research 666:151-67.
15. Paganini-Hill, A. 1996. "Estrogen Replacement Therapy and Risk of Alzheimer's Disease." Archives of Internal Medicine 156:2213-217
16. Prusiner, S. B. 1987. "Prions and Neurodegenerative Diseases." New England Journal of Medicine 317:1571-581.
17. Prusiner, S. B. 1994. "Inherited Prion Diseases." Proceedings of the National Academy of Sciences 91:4611.
18. Reiman, E. M., et al. 1996. "Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for Epsilon 4 Allele for Apolipoprotein E." New England Journal of Medicine 334:752.
19. Roses, A. D., and Saunders, A. M. 1995. "Head Injury, Amyloid Beta and Alzheimer's Disease." Nature Medicine 1:603.
20. Roses, A. D. 1996. "Apolipoprotein E Alleles as Risk Factors in Alzheimer's Disease? Annual Review of Medicine 47:387.
21. Roses, A. D. 1997. "Alzheimer's: The Genetics of Risk." Hospital Practice 32: 51-79.
22. Roskams, A. J., and Connor, J. R. 1990. "Aluminum Access to the Brain: A Role for Transferrin." Proceedings of the National Academy of Science 87: 9024-7.
23. Sano, M. 1997. "Selegiline and A-Tocopherol (Vit. E) as a Treatment for Alzheimer's Disease." New England Journal of Medicine 336: 1216-222.
24. Saxe, S. R., et al. 1999. "Alzheimer's Disease, Dental Amalgam and Mercury." Journal of the American Dental Association 130 (2): 191-99.
25. Schochet, S. S. 1998. "Neuropathology of Aging." Neurologic Clinics: The Neurology of Aging 16 (3): 569-80.
26. Shinobu, L. A., and Beal, M. F. 1997. "The Role of Oxidative Processes and Metal Ions in Aging and Alzheimer's Disease." In J. R. Connor, ed., Metals and Oxidative Damage in Neurological Disorders. New York: Plenum Press.
27. Small, G. W., et al. 1995. "Apolipoprotein E Type 4 Allele and Cerebral Glucose Metabolism in Relatives at Risk for Familial Alzheimer's Disease." Journal of the American Medical Association 273:942.
28. Snowdon, D. A. 1996. "Nun Study: Brain Infarction and Expression of Alzheimer's Disease." Journal of the American Medical Association 277: 813-17.
29. Stewart, W. F. 1997. "Risk of Alzheimer's Disease, Duration of NSAID Use." Neurology 48: 626-32.
30. Terry, R. D., et al. 1991. "Physical Basis of Cognitive Alterations in Alzheimer's Disease: Synapse Loss is the Major Correlate of Cognitive Impairment." Annals of Neurology 30:572-80.
31. Whitson, J. S., Selkoe, D.J., and Cotman, C.W. 1989. "Amyloid Beta-Protein Enhances the Survival of Hippocampal Neurons in Vitro." Science 243:1488-490.